Medically reviewed by Patricia Mikula, PharmD Key Takeaways Beta-blockers may not reduce the risk of death or repeat heart ...

Latest research is challenging decades of established cardiac treatment, revealing that a commonly prescribed class of heart attack medications, beta-blockers may not benefit most patients and could ...

A large new study found that beta blockers did not provide clear benefits for heart attack patients whose hearts were still ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of ...